Company Overview of Appistry Inc.
Appistry Inc. provides analytics and data management solutions to corporations, Fortune 100 companies, and government agencies worldwide. It offers Ayrris, an open, scalable solution for data-intensive applications. The company also provides AYRRIS/BIO–NGS Analytics that employs analytical pipelines designed to automate the analysis and management of specific types of data; and AYRRIS/BIO–Data Management, which provides data management solutions adapted to support NGS Analytics for the life sciences sector. In addition, it offers Ayrris/DEFENSE that offers high-volume data ingest, storage, analysis, and delivery for the intelligence and defense organizations; Appistry CloudDx, a cloud-based ...
10845 Olive Boulevard
St. Louis, MO 63141
Founded in 2001
Key Executives for Appistry Inc.
Compensation as of Fiscal Year 2014.
Appistry Inc. Key Developments
Appistry Appoints Cornelius Boerkoel as Chief Medical Officer
Oct 27 14
Appistry reported that Cornelius Boerkoel, M.D., Ph.D., has joined Appistry's management team as the company's first chief medical officer. Appistry reported that Cornelius Boerkoel, M.D., Ph.D., has joined Appistry's management team as the company's first chief medical officer.
Appistry Inc. Appoints Cornelius (Neal) Boerkoel as Chief Medical Officer
Oct 17 14
Appistry Inc. announced that Cornelius (Neal) Boerkoel has joined Appistry's management team as the company's first chief medical officer. A former laboratory director at the NIH Undiagnosed Diseases Program and co-founder of the Rare Disease Foundation, Boerkoel brings more than 30 years of research and clinical expertise to Appistry, where he will actively participate in developing the company's long-term corporate and product strategy while building relationships with scientific partners and customers. Neal will retain his appointments at the Children's and Women's Medical Centre of British Columbia and the University of British Columbia, where he is a clinical associate professor and clinical investigator in the Provincial Medical Genetics Program and Child and Family Research Institute.
Appistry Teams with Personal Genome Diagnostics to Offer CancerSelect Test through Appistry CloudDx
May 30 14
Appistry, Inc. announced an agreement with Personal Genome Diagnostics to include the company's CancerSelect(TM) panel in Appistry's recently released Appistry CloudDx(TM) genomics testing service. PGDx is among the first organizations to offer lab-developed tests (LDTs) through Appistry's cloud-based service that makes LDTs from leading diagnostic test providers available to physicians across the United States. CancerSelect targets 120 genes of clinical and biological importance to cancer, providing information that can help physicians individualize treatment to a patient's cancer. The CancerSelect panel is sequenced in PGDx's CLIA-certified laboratory, and the analysis is conducted using PGDx's proprietary algorithms that provide extremely high coverage, copy number analyses for 63 genes, and translocation analysis for 17 genes. Appistry will collaborate with PGDx to deliver a report to participating physicians containing a pathological evaluation of the tumor sample; tumor-specific mutations (alterations and substitutions, amplifications, and translocations); a description of mutated genes and pathways along with biologic and clinical implications; full statistics; and therapeutic, predictive, and prognostic information and references, as well as referral information for ongoing clinical trials that might be relevant based on the analysis results. Appistry CloudDx streamlines and simplifies the workflow associated with genomics-based testing, which has been limited in its impact, partly because it requires organizations to amass infrastructure and expertise to deliver relevant results that are usable by physicians. Appistry CloudDx provides a single web dashboard for ordering and tracking the progress of tests and orchestrates the data flow between test providers such as PGDx and requesting physicians and hospitals, thereby ensuring that data and physical samples are transferred and securely managed in accordance with HIPAA and CLIA guidelines.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|